Clinical Trial Update: Simultaneous Integrated Boost (SIB)- IMRT [Phase 2]

View source ↗

Summary

Phase 2 trial update on Simultaneous Integrated Boost IMRT for squamous cell carcinoma, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Squamous Cell

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Carcinoma, Squamous Cell | Phase 2 | Status: COMPLETED